Bernstein Maintains Outperform on Agilon Health, Raises Price Target to $138

Benzinga · 2d ago
Bernstein analyst Lance Wilkes maintains Agilon Health (NYSE:AGL) with a Outperform and raises the price target from $125 to $138.